Cargando…

Evaluation of the Antioxidant Activity of Levetiracetam in a Temporal Lobe Epilepsy Model

Epilepsy is a neurological disorder in which it has been shown that the presence of oxidative stress (OS) is implicated in epileptogenesis. The literature has shown that some antiseizure drugs (ASD) have neuroprotective properties. Levetiracetam (LEV) is a drug commonly used as an ASD, and in some s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ignacio-Mejía, Iván, Contreras-García, Itzel Jatziri, Mendoza-Torreblanca, Julieta Griselda, Medina-Campos, Omar Noel, Pedraza-Chaverri, José, García-Cruz, Mercedes Edna, Romo-Mancillas, Antonio, Gómez-Manzo, Saúl, Bandala, Cindy, Sánchez-Mendoza, María Elena, Pichardo-Macías, Luz Adriana, Cárdenas-Rodríguez, Noemí
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10045287/ https://www.ncbi.nlm.nih.gov/pubmed/36979827 http://dx.doi.org/10.3390/biomedicines11030848

Ejemplares similares

Levetiracetam Mechanisms of Action: From Molecules to Systems
por: Contreras-García, Itzel Jatziri, et al.
Publicado: (2022)

Synaptic Vesicle Protein 2A Expression in Glutamatergic Terminals Is Associated with the Response to Levetiracetam Treatment
por: Contreras-García, Itzel Jatziri, et al.
Publicado: (2021)

Levetiracetam Reduced the Basal Excitability of the Dentate Gyrus without Restoring Impaired Synaptic Plasticity in Rats with Temporal Lobe Epilepsy
por: González-H, Guillermo, et al.
Publicado: (2020)

Therapeutic Potential of Dopamine and Related Drugs as Anti-Inflammatories and Antioxidants in Neuronal and Non-Neuronal Pathologies
por: Bandala, Cindy, et al.
Publicado: (2023)

Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis
por: Mendoza-Torreblanca, Julieta Griselda, et al.
Publicado: (2023)

The Proliferating Cell Nuclear Antigen (PCNA) Transcript Variants as Potential Relapse Markers in B-Cell Acute Lymphoblastic Leukemia
por: Villegas-Ruíz, Vanessa, et al.
Publicado: (2022)

Use of Antioxidants for the Neuro-Therapeutic Management of COVID-19
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2021)

Analysis of Adverse Drug Reactions in Pediatric Patients with Epilepsy: An Intensive Pharmacovigilance Study
por: Hernández García, Ernestina, et al.
Publicado: (2023)

Habilitation of Executive Functions in Pediatric Congenital Heart Disease Patients through LEGO(®)-Based Therapy: A Quasi-Experimental Study
por: Espinosa-Garamendi, Eduardo, et al.
Publicado: (2022)

Levetiracetam Modulates EEG Microstates in Temporal Lobe Epilepsy
por: Ricci, Lorenzo, et al.
Publicado: (2022)

Levetiracetam reduces abnormal network activations in temporal lobe epilepsy
por: Wandschneider, Britta, et al.
Publicado: (2014)

Identification of the antiepileptic racetam binding site in the synaptic vesicle protein 2A by molecular dynamics and docking simulations
por: Correa-Basurto, José, et al.
Publicado: (2015)

Acute Liver Failure Associated with Levetiracetam and Lacosamide Combination Treatment for Unspecified Epileptic Disorder
por: Gutiérrez-Grobe, Ylse, et al.
Publicado: (2013)

TFEB; Beyond Its Role as an Autophagy and Lysosomes Regulator
por: Franco-Juárez, Berenice, et al.
Publicado: (2022)

Seizure Deterioration with Increased Levetiracetam Blood Concentration during the Postpartum Period in Refractory Temporal Lobe Epilepsy
por: Kikumoto, Mai, et al.
Publicado: (2021)

Levetiracetam as an alternative therapy for Tourette syndrome
por: Martínez-Granero, MA, et al.
Publicado: (2010)

Trends in Gliosis in Obesity, and the Role of Antioxidants as a Therapeutic Alternative
por: Bandala, Cindy, et al.
Publicado: (2022)

Levetiracetam in the treatment of epilepsy
por: Abou-Khalil, Bassel
Publicado: (2008)

Levetiracetam-induced pancytopenia
por: Alzahrani, Talal, et al.
Publicado: (2015)

Hypoglycemic Effect of Resveratrol: A Systematic Review and Meta-Analysis
por: García-Martínez, Beatriz Isabel, et al.
Publicado: (2021)

Influence of Age and Dose on the Effect of Resveratrol for Glycemic Control in Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis
por: García-Martínez, Beatriz Isabel, et al.
Publicado: (2022)

Effect of Resveratrol on Markers of Oxidative Stress and Sirtuin 1 in Elderly Adults with Type 2 Diabetes
por: García-Martínez, Beatriz Isabel, et al.
Publicado: (2023)

Computational Study of C-X-C Chemokine Receptor (CXCR)3 Binding with Its Natural Agonists Chemokine (C-X-C Motif) Ligand (CXCL)9, 10 and 11 and with Synthetic Antagonists: Insights of Receptor Activation towards Drug Design for Vitiligo
por: Aguilera-Durán, Giovanny, et al.
Publicado: (2020)

Behavior of Chemokine Receptor 6 (CXCR6) in Complex with CXCL16 Soluble form Chemokine by Molecular Dynamic Simulations: General Protein‒Ligand Interaction Model and 3D-QSAR Studies of Synthetic Antagonists
por: Aguilera-Durán, Giovanny, et al.
Publicado: (2021)

Acetonic and Methanolic Extracts of Heterotheca inuloides, and Quercetin, Decrease CCl(4)-Oxidative Stress in Several Rat Tissues
por: Coballase-Urrutia, Elvia, et al.
Publicado: (2013)

Study of Endogen Substrates, Drug Substrates and Inhibitors Binding Conformations on MRP4 and Its Variants by Molecular Docking and Molecular Dynamics
por: Becerra, Edgardo, et al.
Publicado: (2021)

Levetiracetam in the treatment of childhood epilepsy
por: Wheless, James W
Publicado: (2007)

Role of Levetiracetam in Neonatal Seizure
por: Murty, Yerramilli V.S.S., et al.
Publicado: (2012)

Clinical Pharmacology and Pharmacokinetics of Levetiracetam
por: Wright, Chanin, et al.
Publicado: (2013)

Levetiracetam-induced leukocytoclastic vasculitis
por: Gupta, Mrinal
Publicado: (2017)

Levetiracetam for the Prophylaxis of Migraine in Adults
por: Azeem, Gauhar M, et al.
Publicado: (2021)

Levetiracetam-induced gingival hyperplasia
por: James, J, et al.
Publicado: (2022)

Genetic variations associated with pharmacoresistant epilepsy
por: Cárdenas-Rodríguez, Noemí, et al.
Publicado: (2020)

Serum levetiracetam concentrations after transdermal levetiracetam administration, 3 times daily, to healthy cats
por: Smith, Casey, et al.
Publicado: (2019)

Levetiracetam-induced bullous pemphigoid in a young adult woman
por: Santaliz-Ruiz, Luis E. IV, et al.
Publicado: (2022)

Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats
por: Osuntokun, Opeyemi Samson, et al.
Publicado: (2021)

Lipoproteins and lipid transport :structural and functional concepts, del libro hiperlipidemisa de Richard L. Jackson, Joel D. Morrisett and Antonio M. Gotto, Jr./
por: García Mejía, Itzel
Publicado: (2003)

Monotherapy for partial epilepsy: focus on levetiracetam
por: Gambardella, Antonio, et al.
Publicado: (2008)

Suppression of Myoclonus in Corticobasal Degeneration by Levetiracetam
por: Cho, Jae Wook, et al.
Publicado: (2014)

Efficacy and Tolerability of Intravenous Levetiracetam in Children
por: Aceves, Jose, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_17qrug9v7cq1kcr3cf21ik37ck